Gastrointest Endosc30 Oct 2023
Researchers examined the feasibility and safety of endoscopic resection (ER) for giant esophageal subepithelial lesions (G-SELs) in a large study. They achieved a remarkable 93.3% en bloc resection rate with a low recurrence rate. Some patients experienced adverse events (9.3% intraoperatively and 17.3% postoperatively). A…
Upper Gastrointestinal Tract30 Oct 2023
Esophageal cancer surgery carries significant risks, especially in low and middle-income countries. This study investigated the impact of enhanced recovery protocols (ERP) in patients undergoing esophagectomy in India. Despite ERP patients having a higher predicted risk of complications, they experienced significantly lower 30-day morbidity and…
World J Surg29 Oct 2023
Researchers explored the impact of age on post-operative outcomes for patients undergoing resection for oesophageal and gastric cancer. They analyzed data from a cohort of 466 patients over nearly two decades. Patients over 75 faced slightly higher post-operative complications, primarily cardiac or thromboembolic issues, when…
Surg Endosc27 Oct 2023
A study on 141 patients with duodenal submucosal tumors (SMTs) explored the outcomes of endoscopic resection (ER). Results showed that 78.7% achieved complete resection, but 6.4% faced complications. High-risk factors for complications included SMTs near the duodenal papilla and those with a diameter exceeding 15mm.…
Dig Surg26 Oct 2023
Sarcopenia, a condition involving muscle loss, is common in esophageal cancer patients. This study delved into how sarcopenia, particularly during neoadjuvant chemotherapy (NAC), affects postoperative complications, especially postoperative pneumonia (PP). By analyzing 113 patients, they found that the criteria of the modified European Working Group…
Ann Surg Oncol25 Oct 2023
Researchers assessed the Pan-Immune-Inflammation Value (PIV) as an indicator of neoadjuvant immunochemotherapy (NICT) response in esophageal squamous cell carcinoma. Among 218 patients, PIV was linked to achieving a pathological complete response. High PIV predicted poorer 3-year overall survival and disease-free survival compared to low PIV.…
Surg Endosc25 Oct 2023
This study delves into "surgomics," a method that customizes surgical outcome predictions using machine learning and real-time surgical data. The challenge? Gathering high-quality annotations from experts. To address this, the researchers investigated active learning (AL) to make annotation more efficient. They chose ten video-based features…
Ann Surg24 Oct 2023
Researchers investigated whether adjuvant therapy benefits patients with duodenal adenocarcinoma (DAC) and intestinal subtype ampullary carcinoma (IAC) after surgery. The study found that while DAC patients with perineural invasion and IAC patients with specific risk factors (lymph node involvement, advanced tumor stage, perineural invasion) benefited…
Am J Surg24 Oct 2023
When faced with unresectable gastric cancer causing gastric outlet obstruction (GOO), the choice between stomach partitioning gastrojejunostomy (SPGJ) and conventional gastrojejunostomy (CGJ) matters. In a study involving 108 patients, SPGJ significantly reduced delayed gastric emptying, vomiting, and the need for prokinetics, enhancing patient recovery. Patients…
Ann Surg23 Oct 2023
This study delves into techniques used to reduce complications in esophagectomy, where blood flow issues often lead to problems. They compared three methods: one-step esophagectomy, laparoscopic gastric ischemic conditioning (lapgic), and angioembolization (angiogic). Results from 14 studies involving 1760 patients indicate that both lapgic and…